PMID: 3770039Jul 1, 1986Paper

Placebo controlled pneumococcal immunization in patients with bronchogenic carcinoma

European Journal of Cancer & Clinical Oncology
J KlasterskyA Safary

Abstract

Pneumococcal vaccine [heptadecavalent types 1, 2, 3, 4, 6A, 7F, 8, 9N, 11A, 12F, 14, 15F, 17F, 18C, 19F, 23F and 25 pneumococcal capsular polysaccharide vaccine (Moniarix)] or placebo were evaluated in 26 and 21 patients with bronchogenic carcinoma, most of whom did not receive prior radiotherapy or chemotherapy. No difference was detected as far as clinical outcome is concerned: 3 vaccinated patients out of 26 (11.5%) developed pneumococcal infections (1 fatal bacteremia) and 4/21 (19%) of those who received a placebo presented such an infection (1 fatal bacteremia). The antibody response was significantly increased in the vaccines for types 1, 2, 7F, 8, 9N, 12F, 14, 17F, 18C, 23F and 25.

Citations

Jun 1, 1988·European Journal of Epidemiology·V RichardJ Klastersky
Mar 14, 2003·The Journal of Infection·Neil French
Jan 18, 2011·American Journal of Respiratory and Critical Care Medicine·Kevin C Wilson, Holger J Schünemann
Jan 7, 2009·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Anke HussMatthias Egger
Apr 1, 2014·BMC Infectious Diseases·Jaime E Ordóñez, John J Orozco
Sep 17, 2005·Pharmacotherapy·Angela E Bridy-PappasDaniel J Isaacman
Apr 2, 2005·Clinics in Chest Medicine·Andrew F Shorr
Aug 14, 2012·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·J D Grabenstein, K P Klugman
Nov 30, 2004·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Mark LoebUNKNOWN SHEA Long-Term-Care Committee
Oct 1, 2005·Expert Review of Pharmacoeconomics & Outcomes Research·Pedro Plans-Rubió
May 28, 2005·Expert Review of Anti-infective Therapy·Mark Loeb
Feb 27, 2013·The Cochrane Database of Systematic Reviews·Sarah MoberleyRoss M Andrews
Jan 1, 1990·Annals of the New York Academy of Sciences·D P Taylor
Jan 25, 2017·The Cochrane Database of Systematic Reviews·Julia Ae WaltersRichard Wood-Baker

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Carcinoma, Bronchogenic

Bronchogenic Carcinoma is a malignant lung cancer arising in the epithelium of the bronchus or bronchiole. Discover the latest research on Bronchogenic Carcinoma here.